An Act relative to opioid drug manufacturer assessments
Bill Information
Bill Information
- Sponsor:
- Joint Committee on Mental Health, Substance Use and Recovery
- Status:
- Referred to Joint Committee on Health Care Financing
Bill History
Displaying 9 actions for Bill H.4532
| Date | Branch | Action |
|---|---|---|
| 3/9/2020 | House | Reported from the committee on Mental Health, Substance Use and Recovery |
| 3/9/2020 | House | New draft of H1703 |
| 3/9/2020 | House | Reported favorably by committee and referred to the committee on Health Care Financing |
| 3/23/2020 | House | Reporting date extended to Friday May 1, 2020, pending concurrence |
| 3/26/2020 | Senate | Senate concurred |
| 4/29/2020 | House | Reporting date extended to Friday June 19, 2020, pending concurrence |
| 4/30/2020 | Senate | Senate concurred |
| 6/22/2020 | House | Reporting date extended to Thursday December 31, 2020, pending concurrence |
| 1/5/2021 | House | No further action taken |
The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.